| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.6 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |